Richard William Troughton

机构：Christchurch Hospital, Canterbury Health Laboratories, New Zealand Brain Research Institute, University of Otago · ORCID：0000-0001-7484-4036

发表论文 533 篇 · 总被引 20334 次 · h-index 70

代表论文

• Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2024 · New England Journal of Medicine · 被引 845)
• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)
• Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial (2024 · Circulation · 被引 68)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 46)
• Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF (2025 · Journal of the American College of Cardiology · 被引 28)
• Characterization of Serum Phosphate Levels Over Time with Intravenous Ferric Carboxymaltose Versus Placebo as Treatment for Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Exploratory Prospective Substudy From HEART-FID (2024 · European Journal of Heart Failure · 被引 6)